Prelude Corp
bio & pharma
2. 11-50
Developers of DCISionRT, the first biological risk signature designed specifically for ductal carcinoma in situ (DCIS).
Your Biology, Your Decision®
preludedx.comLaguna Hills, CA, USA
Inaccurate data? Flag it here.Open jobs at Prelude Corp